Search Results

There are 16950 results for: content related to: A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II)

  1. You have free access to this content
    Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR-BMOD Trial


    Volume 19, Issue 1, January 2011, Pages: 110–120, Thomas A. Wadden, John P. Foreyt, Gary D. Foster, James O. Hill, Samuel Klein, Patrick M. O'Neil, Michael G. Perri, F. Xavier Pi-Sunyer, Cheryl L. Rock, Janelle S. Erickson, Holly N. Maier, Dennis D. Kim and Eduardo Dunayevich

    Version of Record online : 6 SEP 2012, DOI: 10.1038/oby.2010.147

  2. Patient-reported quality of life in a randomized placebo-controlled trial of naltrexone/bupropion for obesity

    Clinical Obesity

    Volume 5, Issue 5, October 2015, Pages: 237–244, R. L. Kolotkin, S. Chen, P. Klassen, K. Gilder and F. L. Greenway

    Version of Record online : 29 JUL 2015, DOI: 10.1111/cob.12108

  3. New Drug Targets for the Treatment of Obesity

    Clinical Pharmacology & Therapeutics

    Volume 90, Issue 1, July 2011, Pages: 40–51, AG Powell, CM Apovian and LJ Aronne

    Version of Record online : 8 JUN 2011, DOI: 10.1038/clpt.2011.82

  4. You have free access to this content
    Bupropion SR vs. Placebo for Weight Loss in Obese Patients with Depressive Symptoms

    Obesity Research

    Volume 10, Issue 10, October 2002, Pages: 1049–1056, Adesh K. Jain, Roy A. Kaplan, Kishore M. Gadde, Thomas A. Wadden, David B. Allison, Edwin R. Brewer, Robert A. Leadbetter, Nathalie Richard, Barbara Haight, Brenda D. Jamerson, Kathleen S. Buaron and Alan Metz

    Version of Record online : 6 SEP 2012, DOI: 10.1038/oby.2002.142

  5. Lyman ‘bump’ galaxies – II. A possible signature of massive extremely metal-poor or metal-free stars in z= 3.1 Lyα emitters

    Monthly Notices of the Royal Astronomical Society

    Volume 411, Issue 4, March 2011, Pages: 2336–2352, A. K. Inoue, K. Kousai, I. Iwata, Y. Matsuda, E. Nakamura, M. Horie, T. Hayashino, C. Tapken, M. Akiyama, S. Noll, T. Yamada, D. Burgarella and Y. Nakamura

    Version of Record online : 30 NOV 2010, DOI: 10.1111/j.1365-2966.2010.17851.x

  6. You have free access to this content


    Volume 18, Issue S2, November 2010, Pages: S137–S203,

    Version of Record online : 6 SEP 2012, DOI: 10.1038/oby.2010.159

  7. You have free access to this content
    Bupropion SR Enhances Weight Loss: A 48-Week Double-Blind, Placebo- Controlled Trial

    Obesity Research

    Volume 10, Issue 7, July 2002, Pages: 633–641, Dr. James W. Anderson, Frank L. Greenway, Ken Fujioka, Kishore M. Gadde, James McKenney and Patrick M. O'Neil

    Version of Record online : 6 SEP 2012, DOI: 10.1038/oby.2002.86

  8. Psychological mediators of bupropion sustained-release treatment for smoking cessation


    Volume 103, Issue 9, September 2008, Pages: 1521–1533, Danielle E. McCarthy, Thomas M. Piasecki, Daniel L. Lawrence, Douglas E. Jorenby, Saul Shiffman and Timothy B. Baker

    Version of Record online : 7 AUG 2008, DOI: 10.1111/j.1360-0443.2008.02275.x

  9. You have free access to this content
    A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation

    Journal of Internal Medicine

    Volume 254, Issue 2, August 2003, Pages: 184–192, P. Tønnesen, 1 S. Tonstad, 2 A. Hjalmarson, 3 F. Lebargy, 4 P. I. Van Spiegel, 5 A. Hider, 6 R. Sweet and 6 J. Townsend 6

    Version of Record online : 9 JUL 2003, DOI: 10.1046/j.1365-2796.2003.01185.x

  10. Bupropion SR as an aid to smoking cessation in smokers treated previously with bupropion: A randomized placebo-controlled study

    Clinical Pharmacology & Therapeutics

    Volume 69, Issue 6, June 2001, Pages: 438–444, David H. Gonzales, Mitchell A. Nides, Linda H. Ferry, Robert P. Kustra, Brenda D. Jamerson, Nathan Segall, Luis A. Herrero, Alok Krishen, Addison Sweeney, Kathleen Buaron and Alan Metz

    Version of Record online : 19 JUN 2001, DOI: 10.1067/mcp.2001.115750

  11. You have free access to this content
    Miracle pills for weight loss: what is the number needed to treat, number needed to harm and likelihood to be helped or harmed for naltrexone–bupropion combination?

    International Journal of Clinical Practice

    Volume 64, Issue 11, October 2010, Pages: 1462–1465, L. Citrome

    Version of Record online : 15 SEP 2010, DOI: 10.1111/j.1742-1241.2010.02501.x

  12. Outcomes on the pharmacopsychometric triangle in bupropion-SR vs. buspirone augmentation of citalopram in the STAR*D trial

    Acta Psychiatrica Scandinavica

    Volume 125, Issue 4, April 2012, Pages: 342–348, P. Bech, M. Fava, M. H. Trivedi, S. R. Wisniewski and A. J. Rush

    Version of Record online : 12 NOV 2011, DOI: 10.1111/j.1600-0447.2011.01791.x

  13. Differential Selectivity of Natural and Synthetic Aminoglycosides towards the Eukaryotic and Prokaryotic Decoding A Sites


    Volume 8, Issue 14, September 24, 2007, Pages: 1700–1709, Jiro Kondo, Mariana Hainrichson, Igor Nudelman, Dalia Shallom-Shezifi, Christopher M. Barbieri, Daniel S. Pilch, Eric Westhof and Timor Baasov

    Version of Record online : 20 AUG 2007, DOI: 10.1002/cbic.200700271

  14. You have full text access to this OnlineOpen article
    A comparative evaluation of NB30, NB54 and PTC124 in translational read-through efficacy for treatment of an USH1C nonsense mutation

    EMBO Molecular Medicine

    Volume 4, Issue 11, November 2012, Pages: 1186–1199, Tobias Goldmann, Nora Overlack, Fabian Möller, Valery Belakhov, Michiel van Wyk, Timor Baasov, Uwe Wolfrum and Kerstin Nagel-Wolfrum

    Version of Record online : 2 OCT 2012, DOI: 10.1002/emmm.201201438

  15. You have free access to this content
    Poster Abstracts — Monday, October 3, 2011


    Volume 19, Issue S1, November 2011, Pages: S153–S235,

    Version of Record online : 6 SEP 2012, DOI: 10.1038/oby.2011.225

  16. Kierkegaard's Social Theory

    The Heythrop Journal

    Volume 55, Issue 5, September 2014, Pages: 944–959, J. Michael Tilley

    Version of Record online : 27 MAR 2014, DOI: 10.1111/heyj.12130

  17. Dehydration of Xylose to Furfural over MCM-41-Supported Niobium-Oxide Catalysts


    Volume 6, Issue 4, April 2013, Pages: 635–642, Cristina García-Sancho, Dr. Irantzu Sádaba, Dr. Ramón Moreno-Tost, Prof. Josefa Mérida-Robles, Prof. José Santamaría-González, Dr. Manuel López-Granados and Prof. Pedro Maireles-Torres

    Version of Record online : 19 MAR 2013, DOI: 10.1002/cssc.201200881

  18. Smoking Cessation

    Chronic Obstructive Pulmonary Disease

    Robert A. Stockley, Stephen I. Rennard, Klaus Rabe, Bartolome Celli, Pages: 608–621, 2008

    Published Online : 11 JAN 2008, DOI: 10.1002/9780470755976.ch53

  19. You have free access to this content
    Retrospective Analysis of the Health-Care Costs of Bupropion Sustained Release in Comparison with Other Antidepressants

    Value in Health

    Volume 4, Issue 5, September/October 2001, Pages: 362–369, Amy W. Poret, Cheryl Neslusan, Jean-François Ricci, Shaohung Wang, Zeba M. Khan and Jacqueline W. Kwong

    Version of Record online : 23 DEC 2001, DOI: 10.1046/j.1524-4733.2001.45068.x

  20. Naturalistic, Self-Assignment Comparative Trial of Bupropion SR, a Nicotine Patch, or Both for Smoking Cessation Treatment in Primary Care

    The American Journal on Addictions

    Volume 11, Issue 4, Fall 2002, Pages: 315–331, Paul B. Gold, Robert N. Rubey and Richard T. Harvey

    Version of Record online : 18 FEB 2010, DOI: 10.1080/1055049029008811